About BIVRX
Invenomic Fund Investor Class Shares is a mutual fund specializing in a long-short equity strategy, aiming for long-term capital appreciation. The fund invests primarily in equity securities listed on U.S. markets, utilizing both long and short positions to capitalize on perceived valuation disparities and market inefficiencies. This approach allows the fund to seek returns in varying market environments by maintaining a fully invested long portfolio while adjusting the size of its short exposure as market conditions dictate.
Managed with a focus on fact-based analysis, the fund’s strategy emphasizes in-depth research of financial statements, earnings transcripts, and company filings to form independent investment views. Its portfolio spans a broad range of sectors, with notable allocations in technology, communication services, utilities, energy, and healthcare. The fund typically holds a diversified set of hundreds of positions, with no single holding dominating the portfolio.
As a member of the long-short equity category, Invenomic Fund Investor Class Shares plays a role in providing investors with access to alternative strategies that may help manage risk or enhance returns in diverse market cycles. The fund is characterized by a relatively high expense ratio and a minimum initial investment requirement, reflecting its active management and specialized investment approach.
Fund Family Invenomic
Category Long-Short Equity
Performance Rating Below Average
Risk Rating Above Average
Stock Exchange NASDAQ
Ticker Symbol BIVRX
Share Class Investor Class Shares
Index S&P Composite 1500 TR
BIVRX had a total return of 6.69% in the past year, including dividends. Since the fund's
inception, the average annual return has been 14.89%.
